PFM Health Sciences’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-159,285
| Closed | -$252K | – | 82 |
|
|
2019
Q4 | $252K | Sell |
159,285
-94,605
| -37% | -$150K | 0.01% | 56 |
|
|
2019
Q3 | $1.01M | Buy |
+253,890
| New | +$1.01M | 0.03% | 69 |
|
|
2018
Q4 | – | Sell |
-740,859
| Closed | -$14.2M | – | 133 |
|
|
2018
Q3 | $14.2M | Sell |
740,859
-13,357
| -2% | -$255K | 0.21% | 93 |
|
|
2018
Q2 | $42.7M | Sell |
754,216
-20,077
| -3% | -$1.14M | 0.67% | 53 |
|
|
2018
Q1 | $32.8M | Buy |
774,293
+23,302
| +3% | +$986K | 0.67% | 54 |
|
|
2017
Q4 | $40.2M | Buy |
750,991
+85,093
| +13% | +$4.55M | 0.95% | 43 |
|
|
2017
Q3 | $29.7M | Buy |
665,898
+105,951
| +19% | +$4.73M | 0.58% | 50 |
|
|
2017
Q2 | $27.2M | Buy |
559,947
+355,568
| +174% | +$17.3M | 0.73% | 44 |
|
|
2017
Q1 | $14.8M | Buy |
204,379
+94,728
| +86% | +$6.86M | 0.37% | 70 |
|
|
2016
Q4 | $6.27M | Buy |
109,651
+56,081
| +105% | +$3.21M | 0.18% | 77 |
|
|
2016
Q3 | $6.86M | Sell |
53,570
-102,324
| -66% | -$13.1M | 0.2% | 74 |
|
|
2016
Q2 | $19.4M | Buy |
+155,894
| New | +$19.4M | 0.59% | 43 |
|